在儿科脏病学中以人工智能为动力的洞察力:当前的应用和未来的机会
Arwa Nada1, Yamen Ahmed2, Jieji Hu3
1Department of Pediatrics, Division of Pediatric Nephrology, Loma Linda University Children's Hospital (LLUCH), Loma Linda University (LLU), 11175 Campus St. A1120H, Loma Linda, CA, 92350, USA. anada@llu.edu.
Pediatric nephrology (Berlin, Germany)
|September 16, 2025
概括
人工智能 (AI) 正在通过提高诊断,治疗和研究来彻底改变儿科科. 这项技术为患有脏疾病的儿童提供个性化的护理,同时解决负责任实施的伦理考虑.
科学领域:
- 儿科脏病学 儿科脏病学
- 医疗人工智能 医疗人工智能
- 医疗信息学 医疗信息学
背景情况:
- 人工智能 (AI) 正在越来越多地影响医疗保健,为改善患者护理和运营效率提供了新的途径.
- 儿科科在诊断,治疗个性化和管理行政负担方面面临着挑战.
研究的目的:
- 探索人工智能在儿科脏病学中的变革潜力.
- 突出AI在提高诊断准确性,治疗精度和研究中的作用.
- 解决与人工智能在该领域实施相关的伦理和实际挑战.
主要方法:
- 整合各种数据集 (病史,基因组学,成像,临床记录) 用于人工智能分析.
- 深度学习模型的应用用于图像解释 (超声波,活检) 和病理学.
- 开发人工智能驱动的决策支持系统,聊天机器人和文档工具.
主要成果:
- 人工智能工具可以检测异常,预测急性损伤,并预测疾病的进展.
- 深度学习改善了超声波和活检评估,优化了药物治疗和透析.
- 人工智能增强了患者的参与度,并通过聊天机器人和自动化文档减少了医生倦怠.
结论:
- 人工智能有很大的潜力彻底改变儿科脏病学,使个性化和主动的护理成为可能.
- 解决道德问题,确保数据隐私,最小化偏见和提供培训对于AI集成至关重要.
- 人工智能可以通过识别生物标志物和治疗点来加速研究,促进创新和减少差异.
相关概念视频
Pharmacokinetics in Pediatric Patients: Drug Excretion
212
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
212
Pharmacokinetics in Pediatric Patients: Drug Metabolism
195
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
195
Acute Kidney Injury IV: Diagnostic Studies and Prevention
271
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
271
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
246
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
246
Renal Drug Clearance: Overview
667
Renal clearance is a crucial parameter in pharmacokinetics that quantifies the rate at which the kidneys excrete a drug. It represents a constant fraction of the central volume of distribution containing the drug that the kidney eliminates per unit of time.
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
667
Chronic Kidney Disease III: Interprofessional Care
344
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
344


